Manufacturer copay assistance · Blincyto (J9039) · Amgen
$0/dose · Maximum benefit Maximum not publicly disclosed · Covers Blincyto drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Yes — Amgen SupportPlus Co-pay Assistance from Amgen. Patient pays $0 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $0 per treatment Maximum benefit: Maximum not publicly disclosed. Covers Blincyto drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.